Skip to main content
LBRX
NASDAQ Life Sciences

LB Pharmaceuticals Details $100M Private Placement and Annual Meeting Proposals

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$30.775
Mkt Cap
$882.468M
52W Low
$13.36
52W High
$32.905
52W Position info
130% above low
Off High info
6.5% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

LBRX has more than doubled off its 52-week low of $13.36.

Summary

LB Pharmaceuticals filed its definitive proxy statement, outlining proposals for its annual meeting, including director elections, and providing comprehensive details on a significant $100 million private placement completed in February 2026.


Key Events · Financing and Capital Events · LBRX

  • Annual Meeting Scheduled

    The company scheduled its Annual Meeting of Stockholders for June 3, 2026, to vote on the election of three Class I directors and the ratification of BDO USA, P.C. as its independent auditor.

  • Significant Private Placement Details Disclosed

    Detailed disclosure of a $100 million private placement completed on February 6, 2026, involving the issuance of 3,306,571 shares of common stock and 1,417,107 pre-funded warrants at $21.17 per share/warrant. This transaction represents approximately 11.3% of the company's market capitalization and could result in approximately 16.5% dilution.

  • Director Retirement

    Zachary Prensky will retire from the Board and will not stand for re-election at the upcoming Annual Meeting.

  • Option Repricing Disclosure

    The filing revealed that in September 2025, certain "underwater" stock options held by executive officers and directors were repriced to $15.00 per share, aligning with the company's IPO price.


Analysis · LBRX · Life Sciences

This DEF 14A filing provides full details for LB Pharmaceuticals' upcoming annual meeting, including the election of three Class I directors and the ratification of its independent auditor. Most notably, the filing discloses comprehensive information regarding a significant private placement completed on February 6, 2026, which raised approximately $100 million through the issuance of common stock and pre-funded warrants at $21.17 per share. This capital raise, representing over 11% of the company's market capitalization and potentially diluting existing shareholders by approximately 16.5%, provides substantial funding for the company's operations. The filing also notes the retirement of director Zachary Prensky and details a September 2025 repricing of 'underwater' executive and director stock options to the IPO price of $15.00 per share, a historical event reflecting past compensation adjustments.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LBRX was trading at $30.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $882.5M. The 52-week trading range was $13.36 to $32.91. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LBRX - Latest Insights

LBRX
Nov 05, 2026, 8:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $38.09
Real-time Price: $43.58 info
Change: +$5.49 (+14%) info
Market Cap: $1.41B info
LBRX
Nov 05, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $38.09
Real-time Price: $43.58 info
Change: +$5.49 (+14%) info
Market Cap: $1.41B info
LBRX
Nov 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.09
Real-time Price: $43.58 info
Change: +$5.49 (+14%) info
Market Cap: $1.41B info
LBRX
Oct 01, 2026, 4:05 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $37.28
Real-time Price: $43.58 info
Change: +$6.30 (+17%) info
Market Cap: $1.41B info
LBRX
Aug 11, 2026, 8:10 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $46.76
Real-time Price: $43.58 info
Change: -$3.18 (-7%) info
Market Cap: $1.41B info